Verrica Pharmaceuticals Cash and Cash Equivalents | VRCA

Annual Cash and Cash Equivalents Verrica Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
30.1 M	46.3 M	69.5 M	34.3 M	15.8 M	10.7 M	9.24 M	10.3 M	8.66 M	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
69.5 M	8.66 M	26.1 M

Quarterly Cash and Cash Equivalents Verrica Pharmaceuticals

2026-Q2	2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
11.2 M	20.6 M	21.1 M	15.4 M	29.6 M	46.3 M	23 M	31.9 M	48.9 M	69.5 M	84.3 M	55.1 M	60 M	34.3 M	32.5 M	45.4 M	50.4 M	15.8 M	20.4 M	24.7 M	44.1 M	10.7 M	10.7 M	10.7 M	10.7 M	9.24 M	9.24 M	9.24 M	9.24 M	10.3 M	10.3 M	10.3 M	10.3 M	8.66 M	8.66 M	8.66 M	-	527 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
84.3 M	527 K	25.2 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
Celsion Corporation CLSN	8.78 M	-	-6.63 %	$ 13.9 M	USA
FSD Pharma HUGE	1.91 M	-	5743.5 %	$ 69.7 M	Canada
Synthetic Biologics SYN	13.1 M	-	1.32 %	$ 16.2 M	USA
Dynavax Technologies Corporation DVAX	95.9 M	-	-	$ 2.02 B	USA
I-Mab IMAB	2.14 B	-	-	$ 866 M	China
Corner Growth Acquisition Corp. COOL	21.6 K	-	-0.89 %	$ 114 M	USA
AgeX Therapeutics AGE	3.06 M	-	-10.17 %	$ 12.2 K	USA
Qilian International Holding Group Limited QLI	9.82 M	-	-6.08 %	$ 184 M	China
Happiness Biotech Group Limited HAPP	10.3 M	-	1.35 %	$ 17.8 M	China
Genfit SA GNFT	81.8 M	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	5.57 M	-	-13.47 %	$ 169 M	France
CureVac N.V. CVAC	482 M	-	-	$ 867 M	Germany
Athira Pharma ATHA	69.3 M	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	54 M	-	0.74 %	$ 768 M	Israel
Abcam plc ABCM	89 M	-	-	$ 4.9 B	Britain
Galera Therapeutics GRTX	6.38 M	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	8.53 M	-	-18.52 %	$ 27.3 M	Britain
Hepion Pharmaceuticals HEPA	1.83 M	-	-18.79 %	$ 39.3 K	USA
ARCA biopharma ABIO	46.9 M	-	1052.0 %	$ 415 M	USA
MorphoSys AG MOR	158 M	-	2.43 %	$ 254 M	Germany
Codexis CDXS	50.8 M	$ 1.46	2.82 %	$ 127 M	USA
Ardelyx ARDX	68 M	$ 3.78	1.89 %	$ 911 M	USA
Affimed N.V. AFMD	38.5 M	-	-34.95 %	$ 21.5 M	Germany
Arcutis Biotherapeutics ARQT	42.9 M	$ 23.9	1.01 %	$ 3.04 B	USA
Assembly Biosciences ASMB	58.4 M	$ 36.6	1.3 %	$ 410 M	USA
AnPac Bio-Medical Science Co., Ltd. ANPC	1.87 M	-	-1.58 %	$ 28.1 M	China
Celyad Oncology SA CYAD	12.4 M	-	-	$ 12.5 M	Belgium
Adial Pharmaceuticals ADIL	5.88 M	$ 7.12	6.91 %	$ 4.76 M	USA
Generation Bio Co. GBIO	76.3 M	-	-	$ 344 M	USA
Akero Therapeutics AKRO	340 M	-	-	$ 3.67 B	USA
Cyclacel Pharmaceuticals CYCCP	3.5 M	-	-4.36 %	$ 27 M	USA
Gracell Biotechnologies GRCL	1.45 B	-	-	$ 3.37 B	China
Axsome Therapeutics AXSM	323 M	$ 206.68	0.16 %	$ 10.3 B	USA
GlycoMimetics GLYC	213 M	-	9357.83 %	$ 1.01 B	USA
AnaptysBio ANAB	238 M	$ 56.8	0.94 %	$ 1.63 B	USA
Aeterna Zentaris AEZS	7.31 M	-	5.93 %	$ 314 M	Canada
AVROBIO AVRO	254 M	-	1083.1 %	$ 745 M	USA
BioMarin Pharmaceutical BMRN	1.31 B	$ 66.53	0.15 %	$ 12.8 B	USA
BeiGene, Ltd. BGNE	4.55 B	-	0.49 %	$ 251 B	Cayman-islands
AIkido Pharma AIKI	34 M	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	85.7 M	-	-	$ 1.01 B	USA
Aptose Biosciences APTO	935 K	-	-45.71 %	$ 1.2 M	Canada
Bicycle Therapeutics plc BCYC	628 M	$ 4.3	1.42 %	$ 298 M	Britain
AlloVir ALVR	98.1 M	-	4.14 %	$ 49.1 M	USA
ChromaDex Corporation CDXC	64.8 M	-	-0.88 %	$ 598 M	USA